DrugDevCovid19

Tracking the relevant researches of CADD drug development against COVID-19

Halofantrine

ID MW HBD HBA
37393  500.411
RB NOA Rings logP
11238.61

Function

DrugBank ID:

DB01218


Description:

Halofantrine is an antimalarial. It belongs to the phenanthrene class of compounds that includes quinine and lumefantrine. It appears to inhibit polymerisation of heme molecules (by the parasite enzyme "heme polymerase"), resulting in the parasite being poisoned by its own waste. Halofantrine has been shown to preferentially block open and inactivated HERG channels leading to some degree of cardiotoxicity. [DrugBank]

Targets:

Fe(II)-protoporphyrin IX (Plasmodium falciparum); Potassium voltage-gated channel subfamily H member 2 (Humans); Plasmepsin-2 (Plasmodium falciparum) [DrugBank]

Pharmacodynamics:

Halofantrine is a synthetic antimalarial which acts as a blood schizonticide. It is effective against multi drug resistant (including mefloquine resistant) P. falciparum malaria. [DrugBank]

Structures

SMILES:

CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12

2D structures:  

3D structures:  

Docking in target protein

Receptor: Mpro

Docking Site: Catalytic pocket

Ligand: Halofantrine

Vina score: -7.4

Off-target analysis based on ligand similarity (Homo sapiens)

Step 1 - Target prediction for Halofantrine: SwissTargetPrediction

Tips: Click on the link to jump to the 'SwissTargetPrediction' webserver. Select the species of 'Homo sapiens', and then paste the SMILES of Halofantrine in the SMILES input box.

Step 2 - Blind docking for Halofantrine: CB-Dock

Tips: Click on the link to jump to the 'CB-Dock' webserver. Upload the structure file of target predicted by 'SwissTargetPrediction' and the 2D/3D structure file of Halofantrine to perform blind docking.